Astellas Pharma | 4503 - Sales Revenues

Stock Price
2,150.50
Daily Change
6.50 0.30%
Monthly
0.96%
Yearly
46.14%
Q1 Forecast
2,057.60

Astellas Pharma reported JPY524.32B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Astellas Pharma JPY 524.32B 18.53B Sep/2025
Chugai Pharma JPY 346.3B 13.12B Dec/2025
Daiichi Sankyo JPY 558.11B 57.35B Dec/2025
Eisai JPY 197.36B 5.29B Sep/2025
Kyowa Hakko Kirin JPY 118.8B 7.13B Sep/2025
M3 JPY 84.69B 1.51B Sep/2025
Otsuka Holdings JPY 637.98B 40.05B Sep/2025
Shionogi JPY 147.72B 34.52B Dec/2025
Sumitomo Dainippon JPY 120.62B 1.5B Dec/2025
Takeda JPY 1.19T 80B Dec/2025
Terumo JPY 274.97B 15B Sep/2025